Mellitus Overview

  • Founded
  • 2011
  • Status
  • Private
  • Employees
  • 7
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $2.8M
Latest Deal Amount
  • Investors
  • 6

Mellitus General Information


Developer of a diagnostic device designed to detect gestational diabetes. The company's device is used for the measurement of Glycated CD59 (GCD59) with potential clinical utility in screening, diagnosis and monitoring of diabetes, stratification of complications risk and as a clinical trial test for pharmaceutical development, thereby enabling users to identify the potential risk of gestational diabetes mellitus within minutes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Primary Office
  • CIC Boston
  • 50 Milk Street
  • Boston, MA 02109
  • United States
+1 (617) 000-0000

Mellitus Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Mellitus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 07-May-2019 $2.8M 000.00 Completed Generating Revenue
4. Later Stage VC (Series B) 02-Oct-2018 000 000.00 Completed Generating Revenue
3. Later Stage VC 08-May-2017 00.000 00.000 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2016 $2.22M Completed Generating Revenue
1. Early Stage VC 02-Oct-2013 $2.22M $2.22M Completed Generating Revenue
To view Mellitus’s complete valuation and funding history, request access »

Mellitus Executive Team (6)

Name Title Board Seat Contact Info
John Tagliamonte Chief Executive Officer
Joyce Lonergan Co-Founder & Senior Advisor
Jose Halperin MD Co-Founder & Board Member
Michael Chorev Ph.D Co-Founder & Board Member
Kathy Welch Head of Finance
You’re viewing 5 of 6 executive team members. Get the full list »

Mellitus Board Members (5)

Name Representing Role Since
Christopher De Souza Ph.D Broadview Ventures Board Member 000 0000
Ellie McGuire Polaris Partners Board Member 000 0000
Jose Halperin MD Mellitus Co-Founder & Board Member 000 0000
Michael Chorev Ph.D Mellitus Co-Founder & Board Member 000 0000
Xing Zhao Ph.D Mellitus Board Member 000 0000
To view Mellitus’s complete board members history, request access »

Mellitus Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mellitus Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Dreamers VC Venture Capital Minority 000 0000 000000 0
Orient Life Corporation Minority 000 0000 000000 0
Polaris Partners Venture Capital Minority 000 0000 000000 0
Ariel Southeast Angel Partners Angel Group Minority 000 0000 000000 0
Springboard Enterprises Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »